3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Breast
1
Conditions
Lung Neoplasms
76
Leukemia, Myeloid, Acute
68
Prostatic Neoplasms
66
Carcinoma, Non-Small-Cell Lung
56
Neoplasm Metastasis
55
Breast Neoplasms
51
Multiple Myeloma
42
Colorectal Neoplasms
40
Pancreatic Neoplasms
33
Carcinoma, Renal Cell
32
Myelodysplastic Syndromes
31
Melanoma
31
Leukemia, Lymphocytic, Chronic, B-Cell
29
Triple Negative Breast Neoplasms
28
Ovarian Neoplasms
27
Lymphoma, Large B-Cell, Diffuse
25
Glioblastoma
25
Precursor Cell Lymphoblastic Leukemia-Lymphoma
24
Urinary Bladder Neoplasms
22
Lymphoma
22
Burkitt Lymphoma
21
Squamous Cell Carcinoma of Head and Neck
20
Carcinoma, Hepatocellular
19
Glioma
18
Fallopian Tube Neoplasms
18
Endometrial Neoplasms
17
Oropharyngeal Neoplasms
15
Mouth Neoplasms
15
Lymphoma, Follicular
15
Leukemia, Biphenotypic, Acute
15
Interventions
epigallocatechin gallate
2
Ascorbic Acid
2
semaglutide
1
microcrystalline cellulose
1
dapagliflozin
1
cytisine
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
XENP 1595
1
Vitamin D
1
Topiramate
1
Tirzepatide
1
Tablets
1
Spirometry
1
Specimen Handling
1
Selenium
1
Saline Solution
1
Resistance Training
1
Reperfusion
1
Qsymia
1
Probiotics
1
Pregabalin
1
Platelet Count
1
Plastic Surgery Procedures
1
Phentermine
1
Omeprazole
1
Naltrexone
1
Losartan
1
Liraglutide
1
Ketorolac
1
Ischemic Preconditioning
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Inflammation
×
Specimen Handling
×
1 year
×
Clear all
NCT06150898
2025-06-13
KePreSt
Jules Bordet Institute
Phase 2
Recruiting
112 enrolled